Document is current
Any future updates will be listed below
-
Authors
Purkerson, Madison M.
Amend, Sarah R.
Pienta, Kenneth J.
-
Funding
Funding for this research was provided by:
National Institutes of Health (CA093900, CA093900, CA093900)
Prostate Cancer Foundation
U.S. Department of Defense (CDMRP/PCRP W81XWH-22-1-0680, CDMRP/PCRP W81XWH-22-1-0680, CDMRP/PCRP W81XWH-22-1-0680)
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 17 October 2024
First Online: 20 November 2024
Declarations
:
: K.J.P. discloses that he is a consultant to Cue Biopharma, Inc., an equity holder in PEEL therapeutics, and a founder and equity holder in Keystone Biopharma, Inc, and Kreftect, Inc. S.R.A. discloses that she is an equity holder in Keystone Biopharma, Inc.
